ArticleInternational journal of cardiology. Cardiovascular risk and prevention2025
Evaluation of the beneficial effects of pemafibrate in hypertriglyceridemia with or without alcohol drinking (PAR-CHAT: PARmodia-CHikushi Anti-dyslipidemia Trial).
Yosuke Takamiya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.